CREB1 and epilepsy: Some tool (amoxapine, SNC80), FAERS-positive (clozapine), as well as FAERS-negative (imiquimod, rosiglitazone) compounds induced response element binding protein (CREB)-related pathways involved in regulating gene expression changes in epilepsy [34].